Next gen artificial heart, solar oxygen, what to expect from Delta & more!
July 28, 2021
"Both Matthew and I are so grateful that we’ve been provided an opportunity to participate in something that has the potential to have an impact on so many lives." — Rachel Moore, wife of next-gen heart implant patient at Duke
Duke first to implant next-gen heart
Solar-powered oxygen production
Funding for cell therapies
Universities receive grant to create Alzheimer's app
Vaccine acceptance and behavioral AI
COVID-19 risk factors for younger population
Peptoids and COVID
Delta variant: What can we expect this fall?
July 28, 2021
PUDDLE HOPS: HEALTH TECH
Image courtesy of Duke University School of Medicine
DURHAM, NC—Duke University Hospital is the first to implant a new-generation artificial heart. CARMAT, a medical company focused on heart implant technologies, had received FDA to study patients with end-stage biventricular heart failure last year. Duke was one of just three transplant centers in the U.S. selected to join the study. The team there received specialized training to prepare for implant surgery.
PITTSBURGH, PA—Startup LeanMed has secured the support of the WHO for its new solar-powered oxygen production system. The O₂ Cube will bring medical oxygen to the 40,000 rural health centers around the world that lack grid electricity but have enough sun to make solar energy economically viable.
TALK, the Technology Association of Louisville KY, gears up on Aug. 26-27th for its 5th biennial, live, two-day event called Techfest Louisville which draws tech and business professionals looking to learn more about tech trends, tech policy, entrepreneurial breakthroughs, and how new technologies work. TALK has now been an active tech council since 2014 in the Louisville, KY area, with activities at the state and national level including participating with the CyberReadiness Institute, CompTIA, Connected Nation, Cyber.org, Teachcyber.org, and Code.org.
About the event
Sessions throughout the day will include
5G & Broadband
Sessions will be concurrent. The first two keynotes on Day 1 include a new entrepreneurial startup envisioned by a former Louisvillian Mike Slone in the wine and spirits industry called SimpleLabs-- 1 PM, Aug 26th. “Re-Inventing the Wine and Spirits Industry: A Look at A Simple Labs Startup”—Speaker: Mike Slone, Founder & CEO, Simple Labs; and a deep dive into 5G via a Verizon expert-- 1 PM Session Title: “Mobile Access & 5G” Speaker: Arvin Singh, Managing Director of Verizon 5G & Edge innovation, Verizon.
About the organizers
TALK’s primary mission is workforce and economic development. Techfest Louisville draws 200 people from the region and all-access passes will include two networking and luncheons, a Day 1 cocktail hour, and a mini-tradeshow, over 15 booths to determine where your company needs to engage with technology on the market today. The event is also a chance to get your sneak peek of a brand new venue, Noble Funk Brew Co., 922 S. Second Street, in Louisville.
Supporting players of Techfest include Norton Healthcare, Mirazon, Aspectx, LAL Computing, Marwood Veneer, Cloud Nexus, Volta, V-Soft Consulting, Rapid Scale, Amplify Louisville, Baird, Advanced Business Solutions, Spectrum, Verizon, and Frost, Brown & Todd.
ROCHESTER, MN—A study by a research team at the Mayo Clinic offers new insight into COVID-19 risk factors for younger populations. The team found that people younger than 45 had a greater than threefold increased risk of severe infection if they had cancer, heart disease or blood, neurologic or endocrine disorders.
Peptoids in combatting viruses
LOUISVILLE, KY—A team led by a Stanford University bioengineering professor and Gill Diamond, a professor in the department of oral immunology and infectious diseases at the University of Louisville, has discovered that peptoids can be used to fight a variety of viruses. The researchers discovered that certain peptoids could be used to combat viruses such as SARS-CoV-2.
Delta variant: What can we expect this Fall?
LEXINGTON, KY—With news of the delta variant of COVID spreads comes questions about vaccine effectiveness. A panel at the University of Kentucky and UK HealthCare participated in a discussion about these issues and what we might expect this fall.
Share these stories!
Share stories, offer suggestions or leave a comment!